Heading into the holidays, many of our families are planning meals centered around a delicious turkey, ham or brisket. But a new analysis from NRDC and our partners at Food Animal Concerns Trust shows that our families' health is at significant risk from how these American meats are typically produced.
Just a week before Thanksgiving, there's news that an outbreak of antibiotic-resistant Salmonella, linked to raw turkey, is still spreading; it has sickened 164 people thus far, killing one. Each year, at least 2 million Americans suffer infections caused by drug-resistant bacteria, resulting in more than 23,000 deaths. Those numbers are rising according to experts.
What's that got to do with your holiday dinner planning? Plenty, says our new analysis, released just in time for Antibiotic Awareness Week.
The conventional U.S. livestock industry—in particular its beef, pork and turkey sectors—raises animals with very intensive use of antibiotics that are also important to human medicine (“medically important”). Most of these precious medicines are fed to groups of animals that aren’t sick, a practice commonly although inappropriately used to compensate for stressful and unsanitary living conditions. This is unnecessary—several European countries ended uses in healthy animals years ago, and the European Parliament voted last month to ban them. And it is an important driver of the worsening antibiotic resistance crisis. The World Health Organization warns that if we want antibiotics to remain useful for treating people when they get sick, we simply must use them better and more responsibly.
Fittingly, U.S. consumers increasingly show a preference for buying poultry and meat products produced with fewer or no antibiotics. But our new analysis finds that the conventional U.S. meat industry remains a stubbornly high user of antibiotics. Specifically, we find:
- Livestock consumption of medically important antibiotics in the U.S. has increased in intensity since 2009—meaning we’re still using more of these drugs per kilogram of meat than we did then. That’s in contrast to human medicine, where we saw a decline and then plateau in the same time period, suggesting the medical community is taking expert warnings of the looming resistance crisis more seriously than the meat industry.
- It’s also a striking contrast to Europe, as the U.S. livestock industry is using medically important drugs almost twice as intensively (95 percent more) than the industries in 30 European countries, collectively. And, in the case of pig and cattle production, the U.S. industries are using these precious antibiotics far more intensively than their counterparts in France, the United Kingdom, the Netherlands, and Denmark, all of which are major livestock producers—comparable in size to major livestock-producing states in the U.S..
The good news is there’s a lot of room for quick improvement. We’ve seen that with the right leadership, enormous changes have happened quite rapidly. The U.S. chicken industry is a one example. In just a few years, close to half the industry (and 14 of the top 25 U.S. restaurant chains serving chicken) has made some commitment to curbing unnecessary antibiotics in chicken production, by our estimates.
The United Kingdom, France and the Netherlands also cleaned up their livestock industries in a very short time frame. They reduced the intensity of antibiotics consumed in in livestock production by 34 percent, 47 percent and 64 percent, respectively, between 2010 and 2016. Our analysis makes clear that right now, the conventional cattle, pig and turkey industries in the United States just don’t measure up.
Who among us has not relied on antibiotics? It’s in all of our best interest to keep them working. So as families sit down together to enjoy a meal this holiday season, let's hope the American beef, pork and turkey industries are thinking hard about how better to protect the consumers who buy their products.
 European Medicines Agency, European Surveillance of Veterinary Antimicrobial Consumption project. Eighth ESVAC Report: Sales of veterinary antimicrobial agents in 30 European countries in 2016. October 15, 2018. Access at https://www.ema.europa.eu/documents/report/sales-veterinary-antimicrobia....